Amgen Inc.

AI Score

0

Unlock

297.83
3.56 (1.21%)
At close: Feb 20, 2025, 3:59 PM
297.41
-0.14%
After-hours: Feb 20, 2025, 05:37 PM EST

Amgen Statistics

Share Statistics

Amgen has 537.21M shares outstanding. The number of shares has increased by 0.3% in one year.

Shares Outstanding 537.21M
Shares Change (YoY) 0.3%
Shares Change (QoQ) 0.04%
Owned by Institutions (%) 75.75%
Shares Floating 536.05M
Failed to Deliver (FTD) Shares 83
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 11.43M, so 2.13% of the outstanding shares have been sold short.

Short Interest 11.43M
Short % of Shares Out 2.13%
Short % of Float 2.13%
Short Ratio (days to cover) 3.15

Valuation Ratios

The PE ratio is 34.48 and the forward PE ratio is 13.46. Amgen 's PEG ratio is -0.87.

PE Ratio 34.48
Forward PE 13.46
PS Ratio 4.22
Forward PS 4.2
PB Ratio 23.99
P/FCF Ratio 13.57
PEG Ratio -0.87
Financial Ratio History

Enterprise Valuation

Amgen Inc. has an Enterprise Value (EV) of 207.76B.

EV / Earnings 50.8
EV / Sales 6.22
EV / EBITDA 15.56
EV / EBIT 28.62
EV / FCF 19.99

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 10.23.

Current Ratio 1.26
Quick Ratio 0.95
Debt / Equity 10.23
Total Debt / Capitalization 91.09
Cash Flow / Debt 0.19
Interest Coverage 2.3

Financial Efficiency

Return on equity (ROE) is 0.7% and return on capital (ROIC) is 9.76%.

Return on Equity (ROE) 0.7%
Return on Assets (ROA) 0.04%
Return on Capital (ROIC) 9.76%
Revenue Per Employee 1.19M
Profits Per Employee 146.07K
Employee Count 28.00K
Asset Turnover 0.36
Inventory Turnover 1.84

Taxes

Income Tax 519.00M
Effective Tax Rate 0.11

Stock Price Statistics

The stock price has increased by 5.07% in the last 52 weeks. The beta is 0.56, so Amgen 's price volatility has been higher than the market average.

Beta 0.56
52-Week Price Change 5.07%
50-Day Moving Average 275.57
200-Day Moving Average 305.87
Relative Strength Index (RSI) 58.75
Average Volume (20 Days) 3.74M

Income Statement

In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.

Revenue 33.42B
Gross Profit 20.57B
Operating Income 7.26B
Net Income 4.09B
EBITDA 13.36B
EBIT 7.26B
Earnings Per Share (EPS) 7.56
Full Income Statement

Balance Sheet

The company has 11.97B in cash and 60.10B in debt, giving a net cash position of -48.13B.

Cash & Cash Equivalents 11.97B
Total Debt 60.10B
Net Cash -48.13B
Retained Earnings 0
Total Assets 91.84B
Working Capital 5.93B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.49B and capital expenditures -1.10B, giving a free cash flow of 10.39B.

Operating Cash Flow 11.49B
Capital Expenditures -1.10B
Free Cash Flow 10.39B
FCF Per Share 19.21
Full Cash Flow Statement

Margins

Gross margin is 61.53%, with operating and profit margins of 21.71% and 12.24%.

Gross Margin 61.53%
Operating Margin 21.71%
Pretax Margin 13.79%
Profit Margin 12.24%
EBITDA Margin 39.96%
EBIT Margin 21.71%
FCF Margin 31.1%

Dividends & Yields

AMGN pays an annual dividend of $9.52, which amounts to a dividend yield of 3.24%.

Dividend Per Share $9.52
Dividend Yield 3.24%
Dividend Growth (YoY) 11.74%
Payout Ratio 126.09%
Earnings Yield 2.54%
FCF Yield 6.5%
Dividend Details

Analyst Forecast

The average price target for AMGN is $324, which is 8.8% higher than the current price. The consensus rating is "Hold".

Price Target $324
Price Target Difference 8.8%
Analyst Consensus Hold
Analyst Count 22
Stock Forecasts

Stock Splits

The last stock split was on Nov 22, 1999. It was a forward split with a ratio of 2:1.

Last Split Date Nov 22, 1999
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 1.82
Piotroski F-Score 7